Studies are also required to determine the association between TNF-α/TNFR2 and different BC subtypes, as well as whether the degree of this association affects the aggressiveness of these subtypes in terms of their metastasis, recurrence, and drug resistance to provide an effective targeted therapy in the near future. The gene discussed is TNF; the disease is breast cancer.